Author Correction: Vorasidenib and ivosidenib in IDH1-mutant low-grade glioma: a randomized, perioperative phase 1 trial (Nature Medicine, (2023), 29, 3, (615-622), 10.1038/s41591-022-02141-2)

Ingo K. Mellinghoff, Min Lu, Patrick Y. Wen, Jennie W. Taylor, Elizabeth A. Maher, Isabel Arrillaga-Romany, Katherine B. Peters, Benjamin M. Ellingson, Marc K. Rosenblum, Saewon Chun, Kha Le, Ania Tassinari, Sung Choe, Youssef Toubouti, Steven Schoenfeld, Shuchi S. Pandya, Islam Hassan, Lori Steelman, Jennifer L. Clarke, Timothy F. Cloughesy

Internal Medicine
Neurology & Neurotherapeutics
Hematology & Oncology

Research output: Contribution to journal › Comment/debate › peer-review

Sort by
Weight
Alphabetically

Author Correction: Vorasidenib and ivosidenib in IDH1-mutant low-grade glioma: a randomized, perioperative phase 1 trial (Nature Medicine, (2023), 29, 3, (615-622), 10.1038/s41591-022-02141-2)

Fingerprint

Medicine & Life Sciences